首页> 外文期刊>The Journal of Urology >The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.
【24h】

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

机译:度他雄胺和非那雄胺对5alpha还原酶的抑制作用对健康年轻人的骨矿物质密度,血清脂蛋白,血红蛋白,前列腺特异性抗原和性功能的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Dutasteride and finasteride are 5alpha-reductase inhibitors that dramatically decrease serum levels of dihydrotestosterone. Because androgens affect bone, lipids, hematopoiesis, prostate and sexual function, we determined the impact of 5alpha-reductase inhibitors on these end points. MATERIALS AND METHODS: We conducted a randomized, double-blinded, placebo controlled trial of 99 men 18 to 55 years old randomly assigned to receive 0.5 mg dutasteride (33), 5 mg finasteride (34) or placebo (32) daily for 1 year. Bone mineral density was measured at baseline, after 1 year of treatment and 6 months after drug discontinuation. In addition, markers of bone turnover, fasting serum lipoprotein concentrations, hemoglobin and prostate specific antigen were measured at baseline, after 26 and 52 weeks of treatment, and again 24 weeks after drug discontinuation. Sexual function was assessed at these points by a validated questionnaire. RESULTS: Significant suppression of circulating dihydrotestosterone levels with the administration of dutasteride or finasteride did not significantly affect bone mineral density or markers of bone metabolism. Similarly serum lipoproteins and hemoglobin were unaffected. Serum prostate specific antigen and self-assessed sexual function decreased slightly during treatment with both 5alpha-reductase inhibitors but returned to baseline during followup. CONCLUSIONS: Profound suppression of circulating serum dihydrotestosterone induced by 5alpha-reductase inhibitors during 1 year does not adversely impact bone, serum lipoproteins or hemoglobin, and has a minimal, reversible effect on serum prostate specific antigen and sexual function in normal men. Circulating dihydrotestosterone does not appear to have a clinically significant role in modulating bone mass, hematopoiesis or lipid metabolism in normal men.
机译:目的:度他雄胺和非那雄胺是5α-还原酶抑制剂,可显着降低血清二氢睾丸激素水平。由于雄激素会影响骨骼,脂质,造血功能,前列腺和性功能,因此我们确定了5α-还原酶抑制剂对这些终点的影响。材料与方法:我们进行了一项随机,双盲,安慰剂对照试验,研究对象为99位18至55岁的男性,随机分配接受0.5 mg度他雄胺(33),5 mg非那雄胺(34)或安慰剂(32),为期1年。在治疗1年后和停药后6个月,在基线时测量骨矿物质密度。此外,在基线治疗,治疗26和52周后以及停药后24周再次测量骨转换,空腹血清脂蛋白浓度,血红蛋白和前列腺特异抗原的标志物。在这些时间点,通过经过验证的问卷对性功能进行评估。结果:施用度他雄胺或非那雄胺显着抑制循环中的二氢睾丸激素水平并未显着影响骨矿物质密度或骨代谢指标。同样,血清脂蛋白和血红蛋白也未受影响。两种5α-还原酶抑制剂治疗期间,血清前列腺特异性抗原和自我评估的性功能均略有下降,但在随访期间恢复至基线。结论:5α-还原酶抑制剂在1年内对循环血清二氢睾丸激素的显着抑制不会对骨骼,血清脂蛋白或血红蛋白产生不利影响,并且对正常男性的血清前列腺特异性抗原和性功能影响很小,且可逆。在正常男性中,循环中的二氢睾丸激素似乎在调节骨量,造血或脂质代谢方面没有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号